Changes in Subjective Measures of Cognitive Function in Older Adults From the Initiation Through 12 Months After the Receipt of Chemotherapy
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved..
BACKGROUND: Cognitive impairment has a negative impact on older patients with cancer.
OBJECTIVES: The aim of this study was to evaluate for interindividual differences in 2 subjective measures of cognitive function in older patients (n = 112), as well as determine which demographic, clinical, and symptom characteristics, and levels of physical function, were associated with initial levels and with the trajectory of each of these 2 measures.
METHODS: Cognitive function was assessed using the cognitive function scale from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and the Attentional Function Index at the initiation of chemotherapy and at 1, 3, 6, 9, and 12 months after its initiation. Hierarchical linear modeling was used to assess for interindividual differences in and characteristics associated with initial levels and changes in cognitive function.
RESULTS: Characteristics associated with decreases in Quality of Life Questionnaire Core 30 scores at the initiation of chemotherapy were longer time since the cancer diagnosis and higher depression scores. Characteristics associated with poorer Attentional Function Index scores at enrollment were lower levels of education and higher depression scores. No characteristics were associated with worse trajectories of either cognitive function measure.
CONCLUSION: Some older patients undergoing chemotherapy experience decrements in cognitive function.
IMPLICATIONS FOR PRACTICE: Our findings suggest that clinicians need to assess for depressive symptoms in older patients before the initiation of chemotherapy. Evidence-based interventions (eg, cognitive stimulation, increased physical activity) can be recommended to maintain and increase cognitive function in older oncology patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Cancer nursing - 46(2023), 6 vom: 04. Nov., Seite E365-E374 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Utne, Inger [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 19.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1097/NCC.0000000000001140 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343020203 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343020203 | ||
| 003 | DE-627 | ||
| 005 | 20231226015439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/NCC.0000000000001140 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1143.xml |
| 035 | |a (DE-627)NLM343020203 | ||
| 035 | |a (NLM)35781267 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Utne, Inger |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Changes in Subjective Measures of Cognitive Function in Older Adults From the Initiation Through 12 Months After the Receipt of Chemotherapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Cognitive impairment has a negative impact on older patients with cancer | ||
| 520 | |a OBJECTIVES: The aim of this study was to evaluate for interindividual differences in 2 subjective measures of cognitive function in older patients (n = 112), as well as determine which demographic, clinical, and symptom characteristics, and levels of physical function, were associated with initial levels and with the trajectory of each of these 2 measures | ||
| 520 | |a METHODS: Cognitive function was assessed using the cognitive function scale from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and the Attentional Function Index at the initiation of chemotherapy and at 1, 3, 6, 9, and 12 months after its initiation. Hierarchical linear modeling was used to assess for interindividual differences in and characteristics associated with initial levels and changes in cognitive function | ||
| 520 | |a RESULTS: Characteristics associated with decreases in Quality of Life Questionnaire Core 30 scores at the initiation of chemotherapy were longer time since the cancer diagnosis and higher depression scores. Characteristics associated with poorer Attentional Function Index scores at enrollment were lower levels of education and higher depression scores. No characteristics were associated with worse trajectories of either cognitive function measure | ||
| 520 | |a CONCLUSION: Some older patients undergoing chemotherapy experience decrements in cognitive function | ||
| 520 | |a IMPLICATIONS FOR PRACTICE: Our findings suggest that clinicians need to assess for depressive symptoms in older patients before the initiation of chemotherapy. Evidence-based interventions (eg, cognitive stimulation, increased physical activity) can be recommended to maintain and increase cognitive function in older oncology patients | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Stokke, Kjersti |e verfasserin |4 aut | |
| 700 | 1 | |a Ritchie, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Løyland, Borghild |e verfasserin |4 aut | |
| 700 | 1 | |a Grov, Ellen Karine |e verfasserin |4 aut | |
| 700 | 1 | |a Rasmussen, Hege Lund |e verfasserin |4 aut | |
| 700 | 1 | |a Lindemann, Kristina |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Steven M |e verfasserin |4 aut | |
| 700 | 1 | |a Torstveit, Ann Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Miaskowski, Christine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer nursing |d 1979 |g 46(2023), 6 vom: 04. Nov., Seite E365-E374 |w (DE-627)NLM000373869 |x 1538-9804 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2023 |g number:6 |g day:04 |g month:11 |g pages:E365-E374 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/NCC.0000000000001140 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2023 |e 6 |b 04 |c 11 |h E365-E374 | ||